^
Association details:
Biomarker:CTSL overexpression
Cancer:Lung Adenocarcinoma
Drug Class:Immunotherapy
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Source:
Title:

183P - Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and gene marker CTSL to predict immunotherapeutic response for lung adenocarcinoma: an integrated analysis of bulk and single cell RNA sequencing

Published date:
03/23/2023
Excerpt:
Moreover, though CTSL was an indicator for poor prognosis of LUAD patients, CTSL high expression group was associated with higher ESTIMATE Score, immune checkpoints expression, and lower TIDE score. Several immunotherapeutic cohorts have confirmed the response-predicting significance of CTSL in patients receiving ICI treatment...In conclusion, our study provided an insight into the significant role of APC/T/NK cells-related genes in survival risk stratification and CTSL in response prediction of immunotherapy in patients with LUAD.